br96
Perlick BR96 Parts & Manuals
br96
website br96 This is a phase II trial comparing delivery of the agent doxorubicin either as an immunoconjugate linked to the monoclonal anti-Lewis antibody BR96 or br96 Chimeric BR96 [IgG and F2l immunotoxins were cytotoxic against tumor cell lines displaying the BR96 antigen, with ECgo values ranging from to 110 pM
br96 Immunoconjugates were prepared between chimeric monoclonal antibody BR96 and the anticancer drug doxorubicin The monocional antibody binds an Chimeric BR96 [IgG and F2l immunotoxins were cytotoxic against tumor cell lines displaying the BR96 antigen, with ECgo values ranging from to 110 pM anti-FUT3 immunotoxin BR96 -RTA Suitable for use in Cytotoxicity assay, Functional assay Belongs to the family
Unable to load receipt Availability
